BLUEJET Stock Overview
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 6/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for BLUEJET from our risk checks.
Blue Jet Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹475.65 |
| 52 Week High | ₹538.50 |
| 52 Week Low | ₹319.50 |
| Beta | 0 |
| 11 Month Change | 11.68% |
| 3 Month Change | 25.12% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 15.06% |
Recent News & Updates
Recent updates
Revenue Miss: Blue Jet Healthcare Limited Fell 13% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Aug 10
Blue Jet Healthcare Limited's (NSE:BLUEJET) Price In Tune With Earnings
Jul 26Blue Jet Healthcare's (NSE:BLUEJET) Solid Earnings May Rest On Weak Foundations
Jun 02Blue Jet Healthcare Limited Just Missed Earnings - But Analysts Have Updated Their Models
May 30Shareholder Returns
| BLUEJET | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -6.3% | 1.6% | -1.7% |
| 1Y | n/a | 50.4% | 42.8% |
Return vs Industry: Insufficient data to determine how BLUEJET performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how BLUEJET performed against the Indian Market.
Price Volatility
| BLUEJET volatility | |
|---|---|
| BLUEJET Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: BLUEJET has not had significant price volatility in the past 3 months.
Volatility Over Time: BLUEJET's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 407 | Shiven Arora | www.bluejethealthcare.com |
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally.
Blue Jet Healthcare Limited Fundamentals Summary
| BLUEJET fundamental statistics | |
|---|---|
| Market cap | ₹82.51b |
| Earnings (TTM) | ₹1.57b |
| Revenue (TTM) | ₹6.95b |
52.4x
P/E Ratio11.9x
P/S RatioIs BLUEJET overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLUEJET income statement (TTM) | |
|---|---|
| Revenue | ₹6.95b |
| Cost of Revenue | ₹3.09b |
| Gross Profit | ₹3.86b |
| Other Expenses | ₹2.29b |
| Earnings | ₹1.57b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.07 |
| Gross Margin | 55.54% |
| Net Profit Margin | 22.65% |
| Debt/Equity Ratio | 0.2% |
How did BLUEJET perform over the long term?
See historical performance and comparison